1. Phenyliminophenothiazine based self-organization of polyaniline nanowires and application as redox probe in electrochemical sensors
- Author
-
R. R. Latypov, Ivan I. Stoikov, Alena I. Khadieva, Svetlana Belyakova, Gennady Evtugyn, Vladimir V. Gorbachuk, and Sergey V. Drobyshev
- Subjects
0301 basic medicine ,Multidisciplinary ,Materials science ,Hydroquinone ,Sonication ,lcsh:R ,lcsh:Medicine ,Ascorbic acid ,Electrochemistry ,Redox ,Article ,03 medical and health sciences ,chemistry.chemical_compound ,030104 developmental biology ,0302 clinical medicine ,chemistry ,Chemical engineering ,Nanofiber ,Polyaniline ,lcsh:Q ,lcsh:Science ,Dispersion (chemistry) ,030217 neurology & neurosurgery - Abstract
Synthesis and application of nanostructured materials applicable in the assembly of electrochemical sensors is one of the important trends in material sciences and analytical chemistry. In this work, we have proposed and implemented simple non-template method for assembling nanofibers from the polyaniline ultrasonicated with phenyliminophenothiazine in aqueous media. Two-step procedure including association with emeraldine dispersion and reorganization under ultrasonication led to formation of nanofibrillar structures with average diameter of 20 nm. UV-spectroscopy confirms that association of phenyliminophenothiazine and polyaniline in acidic medium resulted in an intense absorption band at 900–910 nm due to donor-acceptor interaction between the reactants. The material combined emeraldine charge transmission with redox activity of phenyliminophenothiazine was found promising for electrochemical sensing. It was confirmed by comparison of characteristics of appropriate solid-contact sensors based on emeraldine and phenyliminophenothiazine toward Fe(III) ions, ascorbic acid and hydroquinone. In all the cases, the use of phenyliminophenothiazine results in a wider concentration range and more reproducible signal against characteristics of similar sensor based on polyaniline. The applicability of the sensor was confirmed by determination of iron content in commercial medication.
- Published
- 2019